相关实验视频
Updated: Sep 8, 2025

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.6K
使用皮疹外观来区分胆性疹亚型:一个回顾性队列研究
M Nagai1, T Fukumoto1, S Imamura1
1Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan.
American journal of clinical dermatology
|July 27, 2025
概括
胆性疹 (CholU) 呈现出各种皮疹. 像皮一样的皮疹,与典型的皮不同,与低水症有关,在男性中更为常见,这表明有不同的临床亚型.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 胆性疹 (CholU) 是由热量,运动或压力引发的状况.
- 根据皮疹类型对CholU进行分类对于管理至关重要,但研究不足.
- 本研究探讨了CholU的皮疹形态及其临床关联.
研究的目的:
- 调查CholU皮疹类型和临床表型之间的关联.
- 探索CholU不同类型的皮疹潜在的潜在机制.
主要方法:
- 对64名CholU患者的回顾性分析.
- 将它们分为红/红斑 (n=44) 或皮 (n=20) 组.
- 自体汗/血清皮肤测试,亚托皮炎和缺水症的评估.
主要成果:
- 皮组:男性比例较高,缺水症和疼痛.
- 红/红斑组:较高的ASwST阳性,亚托皮炎和.
- 男性性别与皮皮疹有显著的关联;低和疼痛也相关.
结论:
- 霍乱患者表现出各种皮疹,包括皮状的喷发.
- 像皮一样的皮疹与缺水症和男性性有关.
- 疹类型可以帮助区分CholU临床亚型,以有针对性的管理.
相关概念视频
Allergic Reactions
28.5K
Overview
28.5K
Cholinergic Antagonists: Pharmacokinetics
558
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
558
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Allergic Drug Reactions
971
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
971
Cholinergic Receptors: Muscarinic
2.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.9K
Adrenergic Receptors: ɑ Subtype
1.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.7K

